Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
[1] [2] The medication is administered as a once-weekly subcutaneous injection, typically on the same day each week to maintain consistent therapeutic levels in your bloodstream
85 TaguchiK.YamamotoM
Tesamorelin is the only one with current FDA approval and Phase III trial data showing visceral fat reduction
Around Gastrointestinal symptoms, such as nausea, are among the most common
received research funding (paid to institution) from NovoNordisk, Sanofi, Merck, Pfizer, Mylan, Boehringer-Ingelheim
Bronner ME, Simes-Costa M
US$ 25.66
US$ 26.02
US$ 25.00
US$ 28.22
US$ 21.65
